“…[ 14 15 ] Moreover, EAS-EMG abnormalities in MSA may become more evident as the disease progresses, with Sakakibara reporting it in 52% patients in the first year of diagnosis and 83% MSA patients by fifth year of diagnosis. [ 16 ] Recently, Todisco et al . [ 17 ] has explored the prognostic significance of EAS- EMG alterations in MSA and its co-relation with prevalence of bowel/bladder symptoms and poor outcome.…”